Non-Invasive Methods to Predict the Chances of Alzheimer’s Disease
DOI:
https://doi.org/10.52783/jns.v14.2554Keywords:
Alzheimer’s Disease (AD), Convolutional Neural Network (CNN), Mild Cognitive Impairment (MCI), Magnetic Resonance Imaging (MRI), Support Vector Machine (SVM), Open Access Series of Imaging Studies (OASIS) and AlzheimerAbstract
Biomarker integration is an important and imperative process in the research of Alzheimer's condition, where non-invasive information gathered from various sources are integrated for more precise and earlier diagnosis. This paper investigates non-invasive biomarkers, such as MRI imaging, by using CNN and SVM machine learning models for the prediction of development of AD. For Neuroimaging the ADNI dataset is one of the most common datasets used in machine learning applications for Alzheimer's prediction. This work also evaluates the feasibility of other datasets, including the OASIS dataset, given the great value of imaging and clinical data it has. One promising direction in this domain is wearable data, where data collection could be non-invasive. This has enormous potential to enhance the diagnosis reliability and efficiency of non-invasive diagnosis of Alzheimer's. ADNI will have a significant part in the prediction of Alzheimer's due to the comprehensive longitudinal data it offers, the facilitation of biomarker identification, and large-scale data sharing to enable the development of precise early detection models. OASIS also offers complete longitudinal and cross-sectional neuroimaging data, and demographic information to facilitate collaborative research and validation of predictive models. These are indeed important data that will enable us to train powerful algorithms to permit early detection and prognosis for Alzheimer's disease. This study will contribute to extending current predictive methods by integrating these multimodal biomarkers and datasets and providing tools for non-invasive diagnosis in Alzheimer's disease.
Downloads
Metrics
References
Rossini, Paolo Maria, Francesca Miraglia, and Fabrizio Vecchio. "Early dementia diagnosis, MCI‐to‐dementia risk prediction, and the role of machine learning methods for feature extraction from integrated biomarkers, in particular for EEG signal analysis." Alzheimer's & Dementia 18, no. 12 (2022): 2699-2706.
Shanmugavadivel, Kogilavani, V. E. Sathishkumar, Jaehyuk Cho, and Malliga Subramanian. "Advancements in computer-assisted diagnosis of Alzheimer's disease: A comprehensive survey of neuroimaging methods and AI techniques for early detection." Ageing Research Reviews 91 (2023): 102072.
Aberathne, Iroshan, Don Kulasiri, and Sandhya Samarasinghe. "Detection of Alzheimer’s disease onset using MRI and PET neuroimaging: longitudinal data analysis and machine learning." Neural Regeneration Research 18, no. 10 (2023): 2134-2140.
Almatrafi, Sarah, Qaisar Abbas, and Mostafa EA Ibrahim. "A systematic literature review of machine learning approaches for class-wise recognition of Alzheimer’s disease using neuroimaging-based brain disorder analysis." Multimedia Tools and Applications (2024): 1-45.
Tsaliki, Karthik Chowdary. "AI-Driven Hormonal Profiling: A Game-Changer in Polycystic Ovary Syndrome Prevention.", IJRASET,2024, https://doi.org/10.22214/ijraset.2024.61001
Tsaliki, Karthik, B. V. Kiranmayee, and Karnam Akhil. "Revolutionizing Polycystic Ovary Syndrome Prevention with Machine Learning.", ICACECS,2024.
Kavitha, C., Vinodhini Mani, S. R. Srividhya, Osamah Ibrahim Khalaf, and Carlos Andrés Tavera Romero. "Early-stage Alzheimer's disease prediction using machine learning models." Frontiers in public health 10 (2022): 853294.
Beltran, Juan Felipe, Brandon Malik Wahba, Nicole Hose, Dennis Shasha, Richard P. Kline, and Alzheimer’s Disease Neuroimaging Initiative. "Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer’s Disease Neuroimaging (ADNI) database." PloS one 15, no. 7 (2020): e0235663
Winchester, Laura M., Eric L. Harshfield, Liu Shi, AmanPreet Badhwar, Ahmad Al Khleifat, Natasha Clarke, Amir Dehsarvi et al. "Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia." Alzheimer's & Dementia 19, no. 12 (2023): 5860-5871.
Song, Minseok, Hyeyoom Jung, Seungyong Lee, Donghyeon Kim, and Minkyu Ahn. "Diagnostic classification and biomarker identification of Alzheimer’s disease with random forest algorithm." Brain sciences 11, no. 4 (2021): 453.
El-Sappagh, Shaker, Jose M. Alonso, SM Riazul Islam, Ahmad M. Sultan, and Kyung Sup Kwak. "A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer’s disease." Scientific reports 11, no. 1 (2021): 2660.
Vrahatis, Aristidis G., Konstantina Skolariki, Marios G. Krokidis, Konstantinos Lazaros, Themis P. Exarchos, and Panagiotis Vlamos. "Revolutionizing the early detection of Alzheimer’s disease through non-invasive biomarkers: the role of artificial intelligence and deep learning." Sensors 23, no. 9 (2023): 4184.
Bari Antor, Morshedul, AHM Shafayet Jamil, Maliha Mamtaz, Mohammad Monirujjaman Khan, Sultan Aljahdali, Manjit Kaur, Parminder Singh, and Mehedi Masud. "A comparative analysis of machine learning algorithms to predict alzheimer’s disease." Journal of Healthcare Engineering 2021, no. 1 (2021): 9917919.
Liu, Lin, Shenghui Zhao, Haibao Chen, and Aiguo Wang. "A new machine learning method for identifying Alzheimer's disease." Simulation Modelling Practice and Theory 99 (2020): 102023.
Grueso, Sergio, and Raquel Viejo-Sobera. "Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer’s disease dementia: a systematic review." Alzheimer's research & therapy 13 (2021): 1-29.
El-Sappagh, Shaker, Hager Saleh, Farman Ali, Eslam Amer, and Tamer Abuhmed. "Two-stage deep learning model for Alzheimer’s disease detection and prediction of the mild cognitive impairment time." Neural Computing and Applications 34, no. 17 (2022): 14487-14509.
Kumari, Rashmi, Subhranil Das, and Raghwendra Kishore Singh. "Agglomeration of deep learning networks for classifying binary and multiclass classifications using 3D MRI images for early diagnosis of Alzheimer’s disease: a feature-node approach." International Journal of System Assurance Engineering and Management 15, no. 3 (2024): 931-949.
Bazarbekov, Ikram, Abdul Razaque, Madina Ipalakova, Joon Yoo, Zhanna Assipova, and Ali Almisreb. "A review of artificial intelligence methods for Alzheimer's disease diagnosis: Insights from neuroimaging to sensor data analysis." Biomedical Signal Processing and Control 92 (2024): 106023.
Zhao, Xinxing, Candice Ke En Ang, U. Rajendra Acharya, and Kang Hao Cheong. "Application of Artificial Intelligence techniques for the detection of Alzheimer’s disease using structural MRI images." Biocybernetics and Biomedical Engineering 41, no. 2 (2021): 456-473.
Tajammal, Taliah, Syed Khaldoon Khurshid, Abdul Jaleel, Samyan Qayyum Wahla, and Riaz Ahmad Ziar. "Deep Learning‐Based Ensembling Technique to Classify Alzheimer’s Disease Stages Using Functional MRI." Journal of Healthcare Engineering 2023, no. 1 (2023): 6961346.
Chimthanawala, Niyamat MA, Akash Haria, and Sadhana Sathaye. "Non-invasive biomarkers for early detection of Alzheimer’s disease: a new-age perspective." Molecular Neurobiology 61, no. 1 (2024): 212-223.
Kaka, Jhansi Rani, and K. Satya Prasad. "Differential evolution and multiclass support vector machine for alzheimer’s classification." Security and Communication Networks 2022, no. 1 (2022): 7275433.
de Lange, Ann‐Marie G., Claudia Barth, Tobias Kaufmann, Ivan I. Maximov. "Women's brain aging: Effects of sex‐hormone exposure, pregnancies, and genetic risk for Alzheimer's disease." Human brain mapping 41, no. 18 (2020): 5141-5150.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
